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Abstract
Atrial fibrillation (AF) is the most frequent arrhythmia in elderly
people. Findings derived from clinical trials seem to demonstrate that
a rate-control strategy of AF in aged patients improves prognosis if
compared to a rhythm-control one. However, epidemiological studies
concordantly show that the arrhythmia is associated to increased hos-
pitalization and mortality rates. In last years, the proportion of patients
admitted to hospital for AF has progressively increased; this trend is
observed in subjects ≥75 and ≥85 years, while no change was found in
younger cohorts. Importantly, in aged individuals, probably because of
the loss of atrial activity, the increase of heart rate and the irregularity
of RR intervals, AF begins a vicious cycle, leading from heart failure,
through the compromise of functional and neurocognitive status, to
overt disability, dementia and increased mortality. Evidence specifically
aimed at clarifying the effects of arrhythmia management on outcomes
characteristic of aged people is completely lacking. In the elderly, the
question regarding the effects of a rate- or a rhythm-control strategy of
AF should be considered as an aspect of a more complex strategy, ad-
dressed to reduce disability and hospitalizations, and to improve
quality of life and survival.
Atrial fibrillation, hospitalizations 
and mortality in elderly subjects
Atrial fibrillation (AF) is the most frequent arrhythmia of elderly
people with a prevalence of 23% at ages ≥85 years [1]. Real world data
show that, in old subjects, a rate-control approach to AF is preferred
over a rhythm-control one [2]. Indeed, the results of a sub-analysis of
the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Man-
agement) Trial demonstrated that in the group of patients aged 70-80
years, after 3.4 years of follow-up, all-cause mortality was significantly
higher in the rhythm-control arm than in the rate-control one (23 vs 18%,
p=0.010) [3]. However, some evidence seems to demonstrate that the
arrhythmia has a not completely favorable and benign course. In par-
ticular, the same AFFIRM Investigators showed that, when compared to
the presence of AF, the finding of sinus rhythm at the EKG was an in-
dependent predictor of higher survival at the end of the follow-up [4].
The results of the Olmsted County Study evidenced in 4618 subjects
with a mean age of 73 years that the hazard ratio (HR) of mortality was
9.62 times higher than that expected in the general population after the
first 4 months from the diagnosis of AF. Interestingly, mortality risk re-
mained higher (HR=1.66) even after that period and until the end of
the 5.3 years of follow-up [5]. More recently, an analysis from the Olm-
sted County Study, demonstrated that, when compared to controls, not
only mortality was higher in AF subjects living in community (mean
age: 74±14 years; 10.5 vs 4.7 events per 100 person-years, p<0.001), but
also the cumulative rate of hospitalizations (58.8 vs 26.4 events per 100
person-years, p<0.05) [6]. Indeed, administrative data collected
among the Medicare fee-for-service beneficiaries (N=68.374.904)
showed that hospitalization rates for AF progressively and continuously
grew from 1999 to 2013 in subjects aged ≥85 years (2013 - N=1261 per
100.000 person-years; +2.22% per year) and 75-84 years (2013 - N=946
per 100.000 person-years; +0.99% per year), but not in those aged 
65-74 years [7].
AF from a geriatric point of view
Older population with AF often presents a high burden of comorbid
conditions; if compared to a matched cohort of subjects without the ar-
rhythmia, it was possible to find not only an increased prevalence of
chronic heart failure, coronary artery disease and hypertension, but
also a higher proportion of subjects with non-cardiovascular condi-
tions, such as cancer, chronic obstructive pulmonary disease, chronic
renal failure, diabetes and obesity [6]. On the whole, the about 2.5 mil-
lions of Medicare beneficiaries with AF have 6 associated comorbidi-
ties. Aspiration pneumonia and urinary tract infections are among the
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of age [15]. In the same text, it is explicitly specified and recom-
mended that studies are needed to observe if differences exist between
rate- and rhythm-control strategies on clinical outcomes relevant to
older subjects, such as quality of life and functional status [15]. At this
regard, we conducted a small, preliminary study, aimed at evaluating
the impact of sinus rhythm restoration on physical performance of aged
patients with persistent AF.
For this purpose, we studied all consecutive subjects undergoing ex-
ternal cardioversion (ECV) of the arrhythmia in a day-hospital setting.
At baseline and at the follow-up, patients were assessed using the
Short Physical Performance Battery (SPPB). More in detail, SPPB is a
tool of the Comprehensive Geriatric Assessment, exploring functional
status, evaluating balance, gait speed, strength and endurance. The
test scores from 0 to 12 (lowest to highest performance), and it is able
to predict incident disability and mortality. We enrolled 46 patients
(age: 77±7 years). At baseline, the median value of SPPB was 10/12 and
it was inversely associated with the CHA2DS2-VASc score and the pres-
ence of depressive symptoms measured with the Geriatric Depression
Scale. After about 4 months, sinus rhythm was observed in 24/46 pa-
tients (52.2%), and it was associated with a significant improvement of
physical functioning, which was absent in patients with AF relapse
(Figure 1). The effects linked to the presence of sinus rhythm persisted
also at multivariate analysis, with a SPPB score 1.1±0.44 points higher
(p=0.018) than that observed when a new arrhythmic event occurred.
These are preliminary data obtained in a small population. If they will
be confirmed in larger series of patients, the debate on which strategy
adopt in elderly AF individuals will be enriched by new endpoints, more
pertinent to aged subjects.
Conclusions
AF is the most frequent arrhythmia of elderly people. It associates
with a more complex clinical condition. AF seems to be responsible in
community-dwelling individuals of higher hospitalization rates, in-
creased mortality and dementia and disability development. Evidence
guiding the management of older patients is presently lacking. Until
the results of new and specifically age-oriented studies will be com-
pleted, when treating older arrhythmic subjects, we should not just
focus on the alternative between rate- and rhythm control strategies,
but aim to preserve functional and cognitive status, and to reduce the
weight of comorbid conditions, hospitalization rates and mortality.
ten most frequent main diseases in elderly hospitalized patients with
AF as a secondary diagnosis [8]. In this sense, if the arrhythmia de-
velops in elderly population, it may be considered as a marker of a com-
plex clinical condition and, perhaps, of frailty [9]. Indeed, the term
“disability-adjusted life-years” was recently coined when speaking of
the complications related to AF. In particular, the impact of the ar-
rhythmia on functional profile starts to increase in an age-related
manner after 60 years of age both in men and women. This important
link can be explained by some considerations. First of all, the aging
process, cardiovascular risk factors and metabolic alterations can all
predispose to AF development. When the arrhythmia initiates, heart
rate usually increases while atrial contraction and atrio-ventricular
synchrony are lost. This changes usually associates with a reduction of
myocardial contractility and of cardiac output. The events we described
can be related to stroke or to heart failure development [10]. The syn-
ergistic interaction between AF and heart failure can explain the worse
prognosis also in patients implanted with a device for cardiac resyn-
chronization therapy. At this regard, the presence of a permanent AF,
when compared to what observed when sinus rhythm was recorded, as-
sociated to a significantly higher mortality risk (HR=1.63, 95% CI=1-
16-2.30, p=0.005) in the 1787 patients of the InSync/InSync ICD Italian
Registry [11]. Importantly, the Cardiovascular Health Study Investiga-
tors showed that neuro-cognitive profile of subjects experiencing a new
AF episode started to diverge, becoming worse than that observed in
the remaining part of the enrolled population. This experience, led in
5150 patients followed-up for 7 years, represents the first demonstra-
tion in a study with a longitudinal design of the tight link between the
arrhythmia and dementia [12]. Furthermore, it had been already
shown that disturbances of learning and memory significantly grow fol-
lowing AF burden, reaching the highest alteration when chronic forms
of the arrhythmia are present [13]. Similarly, in the Age, Gene/Envi-
ronment Susceptibility-Reykjavik Study, AF population had a lower
score in memory tests than control individuals. Importantly, brain
volume, evaluated with magnetic resonance imaging, progressively re-
duced going from sinus rhythm to paroxysmal and persistent / perma-
nent AF subjects [14]. More recently, the Health, Aging, and Body Com-
position Study, in a prospective cohort of community-dwelling older
adults (N=2753), demonstrated that physical performance, evaluated
with a specific battery of tests (grip strength, 2-minute walk distance,
400-m walking time), had a greater decline after an incident AF than
that observed with a persistent sinus rhythm. This association was ver-
ified in people aged 70, 74, 78 and 82 years during a follow-up lasting
10 years [10]. In summary, in the arrhythmic population, the increased
prevalence of cerebrovascular disease, neuro-cognitive disorders and
heart failure, and the higher burden of comorbidities could exert a
great influence on physical performance and functional status, en-
forcing a path leading from disturbances of mobility, through frank dis-
ability and dementia, to higher mortality rates [10].
Rate- or rhythm-control in elderly AF patients
Evidence regarding the choice between a rate- or a rhythm-control
strategy in elderly AF patients is lacking. In a recent scientific state-
ment about knowledge gaps in cardiovascular care of the older adult
population by the American Heart Association, the American College of
Cardiology and the American Geriatrics Society, when speaking of AF
and atrial flutter, it is reported that even if most trials have enrolled pa-
tients without an upper age limit, age of study cohorts is 5-10 years
younger than the average age of patients with AF in the “real world”.
Therefore, it is unknown whether the findings of these studies can be
generalized to patients ≥75 years of age, and especially those ≥85 years
Figure 1. Changes of Short Physical Performance Battery total score
after external cardioversion of atrial fibrillation, by rhythm at
follow-up. SR, sinus rhythm; AF, atrial fibrillation.
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